Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Zimmer Biomet Holdings, Inc. (ZBH) had Revenue of $2.08B for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$2.08B
Net Income	$152.80M
Cost of Goods Sold	$592.20M
Gross Profit	$1.49B
Operating Expenses	$1.78B
Operating Income	$300.00M
Non-Operating Income/Expense	$-75.40M
Pre-Tax Income	$224.60M
Normalized Pre-Tax Income	$224.60M
Income after Taxes	$153.40M
Income from Continuous Operations	$153.40M
Consolidated Net Income/Loss	$153.40M
Normalized Income after Taxes	$153.40M
EBIT	$300.00M
EBITDA	$571.80M
Weighted-Average Shares Outstanding (Basic)	197.90M
Weighted-Average Shares Outstanding (Diluted)	198.30M
Earnings per Share (EPS) (Basic)	$0.77
Earnings per Share (EPS) (Diluted)	$0.77
Balance Sheet Financials
Current Assets	$5.05B
Property, Plant, and Equipment	$2.18B
Long-Term Assets	$17.81B
Total Assets	$22.87B
Current Liabilities	$2.70B
Long-Term Debt	$6.75B
Long-Term Liabilities	$7.63B
Total Liabilities	$10.33B
Common Equity	$12.53B
Tangible Shareholders Equity	$-2.07B
Shareholders Equity	$12.53B
Common Shares Outstanding	197.90M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$761.00M
Cash Flow from Investing Activities	$-1.49B
Cash Flow from Financial Activities	$739.20M
Beginning Cash	$525.50M
End Cash	$556.90M
Increase/Decrease in Cash	$31.40M
Stock-Based Compensation	$40.80M
Common Stock Dividends Paid	$-95.30M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.87
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.35
Debt to Equity Ratio	0.60
Gross Margin	71.49%
Operating Margin	14.44%
EBIT Margin	14.44%
EBITDA Margin	--
Pre-Tax Profit Margin	10.81%
Profit Margin	7.36%
Free Cash Flow	$526.10M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.24
Receiveable Turnover	1.29
Days Sales in Receivables	69.81
Return on Equity	1.22%
Return on Tangible Equity	-7.42%
Return on Assets	0.67%
Return on Investments	0.80%
Book Value Per Share	$63.34
Free Cash Flow per Share	$2.65
Operating Cash Flow per Share	$3.84

Data from Zacks Investment Research, Inc.